Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michelle Anne Van Name, Cindy Guandalini, Amy Steffen, Anisha Patel & William Tamborlane. (2018) The present and future treatment of pediatric type 2 diabetes. Expert Review of Endocrinology & Metabolism 13:4, pages 207-212.
Read now
Read now
Edurne Lecumberri, Maite Ortega, Marta Iturregui, José Antonio Quesada, Clotilde Vázquez & Domingo Orozco. (2018) Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec. Current Medical Research and Opinion 34:6, pages 1053-1059.
Read now
Read now
Sarah L. Anderson, Jennifer M. Trujillo, John E. Anderson & Robert J. Tanenberg. (2018) Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgraduate Medicine 130:2, pages 229-238.
Read now
Read now
Articles from other publishers (8)
Mahmoud Emad-Eldin, Gehan F Balata, Eman A Elshorbagy, Mona S Hamed & Mohamed S Attia. (2024) Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges. World Journal of Diabetes 15:5, pages 828-852.
Crossref
Crossref
Ylenia Ingrasciotta, Giacomo Vitturi & Gianluca Trifirò. (2024) Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications. Journal of Clinical Medicine 13:7, pages 2113.
Crossref
Crossref
Dilek Yildirim, Cennet Çiriş Yildiz, Emine Ergin & İrem Özbay. (2024) Hypoglycaemia fear, treatment adherence, and the quality of life in patients with type 2 diabetes and its determinants. International Journal of Nursing Practice 30:2.
Crossref
Crossref
Gesine van Mark, Sascha R Tittel, Reinhard Welp, Jörg Gloyer, Stefan Sziegoleit, Ralf Barion, Peter M Jehle, Dieter Erath, Peter Bramlage & Stefanie Lanzinger. (2021) DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care 9:1, pages e002215.
Crossref
Crossref
Jun Suzuki, Tadashi Yamakawa, Mari Oba, Jo Nagakura, Erina Shigematsu, Haruka Tamura, Kenichiro Takahashi, Yoshihisa Okamoto, Rika Sakamoto, Minori Shinoda, Tatsuro Takano, Kazuaki Kadonosono & Yasuo Terauchi. (2019) Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study. Endocrine Journal 66:11, pages 971-982.
Crossref
Crossref
Michelle A. Van Name. 2019. Pediatric Type II Diabetes. Pediatric Type II Diabetes
101
106
.
Harmony Thompson, Helen Lunt, Cate Fleckney & Steven Soule. (2018) Insulin degludec overdose in an adolescent with type 1 diabetes: proactive management including monitoring using the Freestyle Libre flash glucose monitoring system. Endocrinology, Diabetes & Metabolism Case Reports 2018.
Crossref
Crossref
Lori Berard, Noreen Antonishyn, Kathryn Arcudi, Sarah Blunden, Alice Cheng, Ronald Goldenberg, Stewart Harris, Shelley Jones, Upender Mehan, James Morrell, Robert Roscoe, Rick Siemens, Michael Vallis & Jean-François Yale. (2018) Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Diabetes Therapy 9:2, pages 501-519.
Crossref
Crossref